University of Bristol - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
42
About the Report
About the Report
Summary
University of Bristol (UOB) is an educational service provider that offers undergraduate and postgraduate courses and research services. The university offers courses in arts, biomedical sciences, engineering, medical and veterinary sciences, dentistry, science, and social sciences and law. It operates schools of earth sciences, experimental psychology, and nanoscience and quantum information. UOB's sport, exercise and health department offers a network of facilities for healthy student experience. The university collaborates with different organizations to enable them to develop innovative solutions. It also offers research study services. UOB is headquartered in Bristol, the UK.
University of Bristol-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
University of Bristol, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Bristol, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Bristol, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Bristol, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Bristol, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Bristol, Medical Devices Deals, 2012 to YTD 2018 10
University of Bristol, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
University of Bristol, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Azellon Raises USD2 Million in Venture Financing 12
Partnerships 14
Evotec Enters into Partnership with University of Bristol, University of Cambridge and Mario Negri Institute for Pharmacological Research 14
MRC Technology Enters Into Second Research Agreement With University of Bristol 16
MRC Technology Enters Into Agreement With University of Bristol To Develop TrkA Antagonists 17
Licensing Agreements 18
Achieve Life Science Amends Licensing Agreement with University of Bristol 18
Topokine Therapeutics Enters into Licensing Agreement with University of Bristol 19
Equity Offering 20
Pertinax Spin Out from University of Bristol 20
University of Bristol-Key Competitors 21
University of Bristol-Key Employees 22
University of Bristol-Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Government and Public Interest 24
Jul 05, 2018: CRUK awards Bristol researcher GBP1.4 million to investigate cancer growth containment 24
Jun 22, 2018: GBP2.9 million awarded to tackling Antibacterial Resistance in Thailand 25
Jun 22, 2018: GBP12 million in grants to tackle superbugs in a global context 26
May 24, 2018: Bath geriatrician leads GBP2.1m trial into Parkinson's disease at the University of Bristol 27
May 24, 2018: Bristol Professor awarded GBP1.5 million to look deeper into our cell's quality control mechanism 28
May 01, 2018: Discovery of immune cells able to defend against mutating viruses could transform vaccine development 29
Apr 27, 2018: Bristol researchers use gene editing to improve red blood cell transfusion compatibility 30
Apr 05, 2018: Outpatient treatment for cancer condition offers effective new approach for patients 31
Mar 27, 2018: Bristol study on nicotinic receptors and long-term memory could lead to more targeted and effective therapies for dementia 32
Dec 11, 2017: Scientists discover new way to help nerve regeneration in spinal cord injury 33
Nov 16, 2017: Bristol wins grant to tackle antibacterial drug resistance in Thailand 34
Oct 31, 2017: Revolutionary Stem Cell Therapy for Knees, Also Known as Living 'bandage' 35
Aug 21, 2017: Bristol scientists to study oral bacteria that cause heart infection 36
Aug 07, 2017: Study of protein cages strengthens Bristol's position at forefront of synthetic biology 37
May 18, 2017: Cystic fibrosis study offers new understanding of silent changes in genes 38
Product News 39
Jul 28, 2017: Ground-Breaking Alzheimer's Trial Available To Patients Across Northern Ireland 39
Mar 24, 2017: Major breakthrough in the manufacture of red blood cells 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Figure
List of Figures
University of Bristol, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Bristol, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Bristol, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Bristol, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Bristol, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Bristol, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
University of Bristol, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Bristol, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Bristol, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
University of Bristol, Pharmaceuticals & Healthcare, Key Facts 2
University of Bristol, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Bristol, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Bristol, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Bristol, Deals By Therapy Area, 2012 to YTD 2018 9
University of Bristol, Medical Devices Deals, 2012 to YTD 2018 10
University of Bristol, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Azellon Raises USD2 Million in Venture Financing 12
Evotec Enters into Partnership with University of Bristol, University of Cambridge and Mario Negri Institute for Pharmacological Research 14
MRC Technology Enters Into Second Research Agreement With University of Bristol 16
MRC Technology Enters Into Agreement With University of Bristol To Develop TrkA Antagonists 17
Achieve Life Science Amends Licensing Agreement with University of Bristol 18
Topokine Therapeutics Enters into Licensing Agreement with University of Bristol 19
Pertinax Spin Out from University of Bristol 20
University of Bristol, Key Competitors 21
University of Bristol, Key Employees 22
University of Bristol, Subsidiaries 23
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.